
51 - 200 employees
Founded 2019
🧬 Biotechnology
💊 Pharmaceuticals
🔬 Science
💰 $85M Series B on 2022-01
Biotechnology • Pharmaceuticals • Science
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. The company is pioneering CAR T-cell therapies, leveraging the transformational power of T cells to potentially provide sustained, treatment-free remission for autoimmune conditions. Kyverna's lead CAR T-cell therapy candidate, KYV-101, is advancing through clinical trials targeting various autoimmune diseases, including multiple sclerosis, myasthenia gravis, systemic sclerosis, and lupus nephritis. Their pipeline features innovative chimeric antigen receptor (CAR) T-cell therapies in both autologous and allogeneic formats aimed at B cell-driven autoimmune diseases.
🕒 August 11
Executive Director leading medical writing for Kyverna Therapeutics, a biopharmaceutical company developing autoimmune disease cell therapies. Overseeing global regulatory documentation, submission strategy, and Medical Writing organization development.
🇺🇸 United States – Remote
💵 $275k - $300k / year
💰 $85M Series B on 2022-01
⏰ Full Time
🔴 Lead
👨⚕️ Medical Director
👻 Ghost score 6%
🕒 August 10
Accounts Payable Specialist managing Coupa vendor onboarding, invoices, payments, and reconciliations. Supporting Kyverna Therapeutics’ autoimmune cell-therapy finance operations through December 2026.
🇺🇸 United States – Remote
💵 $40 - $50 / hour
💰 $85M Series B on 2022-01
⏳ Contract/Temporary
🟡 Mid-level
🟠 Senior
📝 Accounts Payable
👻 Ghost score 6%
🕒 August 9
Director training Medical and Commercial teams for Kyverna Therapeutics, a clinical-stage biopharmaceutical company developing autoimmune cell therapies. Building compliant onboarding, certification, and capability programs for advanced therapy commercialization.
🇺🇸 United States – Remote
💵 $210k - $245k / year
💰 $85M Series B on 2022-01
⏰ Full Time
🔴 Lead
👔 Director
👻 Ghost score 6%
🕒 August 8
Senior medical writer authoring FDA regulatory documents for Kyverna Therapeutics’ autoimmune cell therapy programs. Supporting clinical development, FDA interactions, and regulatory milestones across cross-functional teams.
🇺🇸 United States – Remote
💵 $170k - $190k / year
💰 $85M Series B on 2022-01
⏰ Full Time
🟠 Senior
✏️ Content Writer
👻 Ghost score 6%
🕒 August 7
Contract medical writer authoring FDA regulatory documents for Kyverna Therapeutics’ autoimmune cell-therapy programs. Supporting clinical protocols, agency interactions, and critical regulatory milestones.
🇺🇸 United States – Remote
💵 $170 - $190 / hour
💰 $85M Series B on 2022-01
⏳ Contract/Temporary
🟠 Senior
🔴 Lead
🏥📝 Medical Writer
👻 Ghost score 6%
🕒 August 7
Executive Director leading lifecycle strategies for Kyverna Therapeutics’ autoimmune cell therapy programs. Aligning research, clinical, manufacturing, regulatory, and commercial teams from discovery through launch and lifecycle management.
🇺🇸 United States – Remote
💵 $270k - $305k / year
💰 $85M Series B on 2022-01
⏰ Full Time
🟠 Senior
👔 Director
👻 Ghost score 6%
🕒 July 28
Senior Clinical Trial Manager leading operational delivery of cell therapy clinical trials at Kyverna Therapeutics. Overseeing timelines, budget, quality, and cross-functional coordination for assigned studies.
🏄 California – Remote
💵 $155k - $180k / year
💰 $85M Series B on 2022-01
⏰ Full Time
🟠 Senior
🧪 Clinical Research
👻 Ghost score 6%
🕒 July 17
Associate Director, TMF Lead at Kyverna Therapeutics leading in-house Trial Master File function. Ensuring TMF quality and regulatory alignment for clinical programs.
🇺🇸 United States – Remote
💵 $160k - $180k / year
💰 $85M Series B on 2022-01
⏰ Full Time
🟠 Senior
👔 Director
👻 Ghost score 6%
🕒 July 8
Executive Director providing regulatory leadership for Kyverna's cell therapy portfolio. Shaping regulatory strategy from development through approval and working with cross-functional teams.
🇺🇸 United States – Remote
💵 $270k - $300k / year
💰 $85M Series B on 2022-01
⏰ Full Time
🔴 Lead
🚔 Compliance
👻 Ghost score 9%
🕒 July 2
Vice President of Sales at Kyverna Therapeutics leading U.S. commercial sales for CAR-T therapies. Responsible for building high-performing sales organization and executing go-to-market strategy.
🇺🇸 United States – Remote
💵 $300k - $340k / year
💰 $85M Series B on 2022-01
⏰ Full Time
🔴 Lead
👔 Vice President
👻 Ghost score 11%
🕒 June 25
Medical Science Liaison focusing on CAR-T therapies for autoimmune diseases at Kyverna Therapeutics. Engaging with healthcare professionals and supporting clinical research collaborations within the territory.
🇺🇸 United States – Remote
💵 $170k - $210k / year
💰 $85M Series B on 2022-01
⏰ Full Time
🟠 Senior
👻 Ghost score 13%
🕒 June 12
Director responsible for commercial channel infrastructure for CAR T therapy delivery at Kyverna Therapeutics. Leading distribution strategies and collaborating with multiple departments to ensure compliance and effectiveness.
🇺🇸 United States – Remote
💵 $190k - $230k / year
💰 $85M Series B on 2022-01
⏰ Full Time
🔴 Lead
⚙️ Operations
👻 Ghost score 17%
🕒 June 8
Vice President, Lifecycle Leader at Kyverna Therapeutics driving clinical and regulatory strategies. Leading the company's therapeutic programs toward regulatory approval and commercialization.
🇺🇸 United States – Remote
💵 $300k - $340k / year
💰 $85M Series B on 2022-01
⏰ Full Time
🟠 Senior
👔 Vice President
👻 Ghost score 19%
🕒 May 18
Medical Director/Sr. Medical Director overseeing CAR T-cell therapy clinical trials for autoimmune diseases. Collaborating with teams on design, execution, and regulatory compliance in clinical development.
🇺🇸 United States – Remote
💵 $330k - $370k / year
💰 $85M Series B on 2022-01
⏰ Full Time
🟠 Senior
👨⚕️ Medical Director
👻 Ghost score 26%